345 related articles for article (PubMed ID: 23324907)
1. Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis.
Başar O; Akbal E; Köklü S; Tuna Y; Koçak E; Başar N; Tok D; Erbiş H; Senes M
Herz; 2013 Jun; 38(4):417-22. PubMed ID: 23324907
[TBL] [Abstract][Full Text] [Related]
2. Serum H-FABP levels in patients with hypothyroidism.
Gunes F; Asik M; Temiz A; Vural A; Sen H; Binnetoglu E; Bozkurt N; Tekeli Z; Erbag G; Ukinc K; Akbal E
Wien Klin Wochenschr; 2014 Nov; 126(21-22):727-33. PubMed ID: 25234940
[TBL] [Abstract][Full Text] [Related]
3. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
Dogru T; Genc H; Tapan S; Aslan F; Ercin CN; Ors F; Kara M; Sertoglu E; Karslioglu Y; Bagci S; Kurt I; Sonmez A
Clin Endocrinol (Oxf); 2013 May; 78(5):712-7. PubMed ID: 22676641
[TBL] [Abstract][Full Text] [Related]
4. Heart-type fatty acid binding protein (H-FABP): relationship with arterial intima-media thickness and role as diagnostic marker for atherosclerosis in patients with ımpaired glucose metabolism.
Karbek B; Özbek M; Bozkurt NC; Ginis Z; Güngünes A; Ünsal IÖ; Cakal E; Delibası T
Cardiovasc Diabetol; 2011 May; 10():37. PubMed ID: 21535886
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians.
Thakur ML; Sharma S; Kumar A; Bhatt SP; Luthra K; Guleria R; Pandey RM; Vikram NK
Atherosclerosis; 2012 Aug; 223(2):507-11. PubMed ID: 22748277
[TBL] [Abstract][Full Text] [Related]
6. Serum adipocyte fatty acid-binding protein levels: An indicator of non-alcoholic fatty liver disease in Chinese individuals.
Xu Y; Ma X; Pan X; He X; Wang Y; Bao Y
Liver Int; 2019 Mar; 39(3):568-574. PubMed ID: 30554468
[TBL] [Abstract][Full Text] [Related]
7. Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients.
Koh JH; Shin YG; Nam SM; Lee MY; Chung CH; Shin JY
Diabetes Care; 2009 Jan; 32(1):147-52. PubMed ID: 18835952
[TBL] [Abstract][Full Text] [Related]
8. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
Suh JB; Kim SM; Cho GJ; Choi KM
Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
[TBL] [Abstract][Full Text] [Related]
9. Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.
Gill C; Vatcheva KP; Pan JJ; Smulevitz B; McPherson DD; Fallon M; McCormick JB; Fisher-Hoch SP; Laing ST
Am J Cardiol; 2017 Jun; 119(11):1717-1722. PubMed ID: 28395890
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease.
Kucukazman M; Ata N; Yavuz B; Dal K; Sen O; Deveci OS; Agladioglu K; Yeniova AO; Nazligul Y; Ertugrul DT
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):147-51. PubMed ID: 23085576
[TBL] [Abstract][Full Text] [Related]
11. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
[TBL] [Abstract][Full Text] [Related]
12. Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects.
Kim YC; Cho YK; Lee WY; Kim HJ; Park JH; Park DI; Sohn CI; Jeon WK; Kim BI; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Kim SW; Ryu SH
J Nutr Biochem; 2011 Mar; 22(3):289-92. PubMed ID: 20579864
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease.
Yari FA; Shabani P; Karami S; Sarmadi N; Poustchi H; Bandegi AR
BMC Endocr Disord; 2021 Aug; 21(1):153. PubMed ID: 34344333
[TBL] [Abstract][Full Text] [Related]
14. Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?
Dogru T; Genc H; Tapan S; Ercin CN; Ors F; Aslan F; Kara M; Sertoglu E; Bagci S; Kurt I; Sonmez A
Diabetes Res Clin Pract; 2012 Apr; 96(1):47-52. PubMed ID: 22189171
[TBL] [Abstract][Full Text] [Related]
15. Liver fatty acid-binding protein as a diagnostic marker for non-alcoholic fatty liver disease.
Akbal E; Koçak E; Akyürek Ö; Köklü S; Batgi H; Şenes M
Wien Klin Wochenschr; 2016 Jan; 128(1-2):48-52. PubMed ID: 25447969
[TBL] [Abstract][Full Text] [Related]
16. High Irisin levels in nondiabetic HIV-infected males are associated with insulin resistance, nonalcoholic fatty liver disease, and subclinical atherosclerosis.
Moreno-Perez O; Reyes-Garcia R; Muñoz-Torres M; Merino E; Boix V; Reus S; Giner L; Alfayate R; Garcia-Fontana B; Sanchez-Paya J; Picó A; Portilla J
Clin Endocrinol (Oxf); 2018 Oct; 89(4):414-423. PubMed ID: 29947044
[TBL] [Abstract][Full Text] [Related]
17. Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease.
Beysel S; Kizilgul M; Ozbek M; Caliskan M; Kan S; Apaydin M; Ozcelik O; Cakal E
Clin Interv Aging; 2017; 12():2063-2068. PubMed ID: 29255351
[TBL] [Abstract][Full Text] [Related]
18. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
[TBL] [Abstract][Full Text] [Related]
19. Serum adipocyte fatty acid binding protein levels are positively associated with subclinical atherosclerosis in Chinese pre- and postmenopausal women with normal glucose tolerance.
Hao Y; Ma X; Luo Y; Shen Y; Dou J; Pan X; Bao Y; Jia W
J Clin Endocrinol Metab; 2014 Nov; 99(11):4321-7. PubMed ID: 25127012
[TBL] [Abstract][Full Text] [Related]
20. The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children.
Gökçe S; Atbinici Z; Aycan Z; Cınar HG; Zorlu P
Pediatr Cardiol; 2013 Feb; 34(2):308-15. PubMed ID: 22875138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
